Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin-Tigecycline vs Colistin-Meropenem for MDR Klebsiella pneumoniae BSI
NCT04489459Phase 4Unknown
- Sponsor
- Al-Azhar University
- Start
- Sep 2019
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of tigecycline, meropenem in Klebsiella pneumoniae infection, sponsored by Al-Azhar University. Status: unknown.
02
Drugs
tigecyclinemeropenem
03
Conditions
Klebsiella pneumoniae infection
Beyond the preview
Go deeper on NCT04489459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04489459.